J.W. Cole Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,261
| Closed | -$269K | – | 953 |
|
|
2024
Q2 | $269K | Buy |
2,261
+34
| +2% | +$4.04K | 0.01% | 745 |
|
|
2024
Q1 | $237K | Buy |
2,227
+5
| +0.2% | +$532 | 0.01% | 776 |
|
|
2023
Q4 | $221K | Buy |
2,222
+174
| +8% | +$17.3K | 0.01% | 731 |
|
|
2023
Q3 | $212K | Sell |
2,048
-77
| -4% | -$7.96K | 0.02% | 668 |
|
|
2023
Q2 | $258K | Sell |
2,125
-346
| -14% | -$42K | 0.02% | 623 |
|
|
2023
Q1 | $379K | Buy |
2,471
+145
| +6% | +$22.3K | 0.03% | 521 |
|
|
2022
Q4 | $418K | Sell |
2,326
-127
| -5% | -$22.8K | 0.03% | 462 |
|
|
2022
Q3 | $290K | Sell |
2,453
-858
| -26% | -$101K | 0.02% | 550 |
|
|
2022
Q2 | $473K | Sell |
3,311
-1,453
| -30% | -$208K | 0.04% | 420 |
|
|
2022
Q1 | $821K | Buy |
4,764
+1,230
| +35% | +$212K | 0.06% | 325 |
|
|
2021
Q4 | $898K | Sell |
3,534
-2,353
| -40% | -$598K | 0.06% | 320 |
|
|
2021
Q3 | $2.27M | Buy |
5,887
+532
| +10% | +$205K | 0.16% | 90 |
|
|
2021
Q2 | $1.26M | Sell |
5,355
-355
| -6% | -$83.4K | 0.1% | 233 |
|
|
2021
Q1 | $748K | Buy |
5,710
+3,741
| +190% | +$490K | 0.07% | 297 |
|
|
2020
Q4 | $206K | Sell |
1,969
-1,462
| -43% | -$153K | 0.02% | 588 |
|
|
2020
Q3 | $243K | Buy |
+3,431
| New | +$243K | 0.02% | 609 |
|